Researchers are developing new, portable breath analysis tools to diagnose tuberculosis and other diseases, making screenings more accessible in remote areas and beyond.
Slight modifications to glycoproteins reveal critical insights into disease onset, state, and progression, making them a wellspring for biomarker discovery.
LIVE September 13th, 2021 at 11:00 AM ET In this webinar, Shane Needham will discuss methods to optimize protein quantification workflows and introduce a new HRAMS system, the ZenoTOF 7600.
Quantifying biotherapeutics in biological matrices plays a critical role in the drug discovery and development process. Ligand binding assays often lack the sensitivity to detect low-concentration analytes, particularly with limited sample supply.